Listen "Looking into the horizon of CAR-T cell therapies"
Episode Synopsis
In the current episode of “Immuno Oncology Talks”, we discuss the clinical challenges and future perspectives of CAR-T cells with our experts, from the Oslo University Hospital in Norway, Dr Else Marit Inderberg and Dr Sébastien Wälchli. Dr Inderberg is the head of the immunomonitoring at the hospital and has a research focus on novel immunotherapies, and Dr Wälchli is leading the CAR development platform. MAT-BE-2400334 (ver.1.0) 04 2024
More episodes of the podcast Immuno Oncology Talks
Oncogenes in relation to immune responses
16/02/2024
NK cell-based cancer immunotherapies
28/09/2022
Biology of Natural Killer (NK) cells
28/09/2022